Deqi Medicine - B(06996.HK) Granted a total of 1.9 million share options and 250k restricted share units

NightAirdropper · 2026-04-07T17:12:54+00:00

Deqi Medicine-B announces the grant of 1.9 million share options and 250k restricted stock units to five grantees, subject to the terms of the relevant plan. The share options include 1.3 million granted to employees and 600k granted to executive directors.

NightAirdropper

2026-04-07 17:12:54

Abstract generation in progress

Gelonghui April 7丨Deqi BioPharma-B (06996.HK) announced that on April 2, 2026, the company granted an aggregate of 1.9 million share options to five grantees under the 2020 equity incentive plan, and granted 250,000 restricted share units to four of those grantees under the 2022 restricted share unit plan, which shall become effective only after the grantees accept the grants and comply with the Listing Rules and the respective terms of the 2020 equity incentive plan and the 2022 restricted share unit plan.

Of the total 1.9 million share options, (i) 1.3 million share options were granted to four grantees, who are employees of the Group, and are not connected persons of the company; and (ii) 600,000 share options were granted to one grantee, who is the company’s executive director and a substantial shareholder. All 250,000 restricted share units were granted to four grantees, who are employees of this Group, and are not connected persons of the company.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.